Single-Site Fe-N-C Atom Based Carbon Nanotubes for Mutually Promoted and Synergistic Oncotherapy

ACS Appl Mater Interfaces. 2022 Nov 2;14(43):48356-48367. doi: 10.1021/acsami.2c11809. Epub 2022 Oct 25.

Abstract

A carbon nanotube (CNT) supported single-site Fe-N-C catalyst (CNTs/Fe-N-C) exhibited attractive properties in peroxidase (POD)-like activity and photothermal effect. Herein, we designed a therapeutic platform by wrapping doxorubicin (DOX) in mesoporous CNTs/Fe-N-C with the cell membrane (CM) of breast cancer. The ultimate nanoagent (CNTs/Fe-N-C/DOX/CM) exhibited high antitumor activity on account of its efficient catalytic ability, increased drug release rates, and significant photothermal effect. Due to the POD-like activity, CNTs/Fe-N-C could effectively catalyze hydrogen peroxide (H2O2) into cytotoxic hydroxyl radicals (OH) for chemodynamic therapy (CDT) of the tumor. Besides, the released DOX not only merely induced the diagnosis of the tumor cells for chemotherapy (CT) but also generated H2O2 to promote CDT. Moreover, the photothermal effect of the nanoagent could use for photothermal therapy (PTT). The increasing temperature was conducive to the release of DOX from micropore into the cell, which indirectly enhanced CT and CDT effects. As an intelligent and multifunctional drug delivery platform, the present CNTs/Fe-N-C/DOX/CM nanoagent could be engineered with synergistic treatments and favorable biosafety, which provides a promising paradigm in site-specific antitumor treatment and biomedicine.

Keywords: cell membrane; chemodynamic therapy; chemotherapy; photothermal therapy; single-site catalysts.

MeSH terms

  • Breast Neoplasms* / drug therapy
  • Cell Line, Tumor
  • Doxorubicin / pharmacology
  • Drug Liberation
  • Female
  • Humans
  • Hydrogen Peroxide
  • Nanoparticles*
  • Nanotubes, Carbon*
  • Neoplasms* / drug therapy

Substances

  • Nanotubes, Carbon
  • Hydrogen Peroxide
  • Doxorubicin